MAIA Pharma

BORTEZOMIB (MAIA)

Manufacturer:

MAIA Pharma

Bortezomib (Maia) HCPCS:

J9051

HCPCS Code Descriptor:

Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg

Category:

J Code

Bortezomib (Maia) NDCs:

70511-0161-05, 70511-0162-02

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Bortezomib (Maia):

Bortezomib (Maia) is an Oncology drug manufactured by Maia and administered via the Intravenous route of administration. The J Code: J9051 is aligned to the drug Bortezomib (Maia).

ACCESS PRICING AND MORE BY REGISTERING

J9051 Added Date:

October 1, 2023

J9051 Effective Date:

October 1, 2023

J9051 Termination Date:

We have not yet identified a manufacturer source of Bortezomib (Maia) billing and coding information.
BORTEZOMIB (MAIA) prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for BORTEZOMIB (MAIA). Please check back in a few weeks.